PCRX (STOCKS)
Pacira BioSciences, Inc. Common Stock
$21.730000
+0.490000 (+2.31%)
Prev close: $21.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Frank D. Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $945.54M
- Employees
- 790
- P/E (TTM)
- 48.71
- P/B (TTM)
- 1.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.70 | $0.66 | +0.0351 | +5.28% |
|
Jun 2025 (Q2)
|
$0.74 | $0.72 | +0.0155 | +2.14% |
|
Mar 2025 (Q1)
|
$0.62 | $0.61 | +0.0121 | +1.99% |
|
Dec 2024 (Q4)
|
$0.91 | $0.85 | +0.0580 | +6.81% |
Financial Statements
| Assets | $1.30B |
| Current Assets | $562.75M |
| Inventory | $157.68M |
| Other Current Assets | $405.07M |
| Noncurrent Assets | $734.83M |
| Fixed Assets | $147.39M |
| Intangible Assets | $382.40M |
| Other Non-current Assets | $205.04M |
| Liabilities | $570.36M |
| Current Liabilities | $107.08M |
| Accounts Payable | $17.69M |
| Other Current Liabilities | $89.39M |
| Noncurrent Liabilities | $463.29M |
| Long-term Debt | $376.72M |
| Other Non-current Liabilities | $86.56M |
| Equity | $727.21M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $727.21M |
| Liabilities And Equity | $1.30B |